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ABSTRACT
BACKGROUND: Skin flaps are among the basic treatment options in the recon-
struction of soft tissue defects. To improve skin flap survival, a variety of methods,
including pharmacologic agents, have been investigated. The effectiveness of antico-
agulants, antioxidants, anti-inflammatory drugs, and vasodilatory drugs in improving
flap survival has been studied. Nebivolol is a new-generation selective ~l-adrenoreceptor
blocking agent that has vasodilatory, anti thrombotic, antioxidative, and anti-
inflammatory effects.
OBJECTIVE: The aim of this experimental study was to investigate the effects of
nebivolol (50 mg/kg/d) on random pattern skin flap survival in rats.
METHODS: Male Wistar rats weighing 290 to 310 g were randomly divided into
2 groups-the nebivolol group and the control group. Random patterned, caudally-
based, -3 x 10-cm skin flaps were elevated on the back of each rat. In the nebivolol
group, nebivolol 50 mg/kg/d (l mL of a racemic solution of nebivolol) was adminis-
tered orally 2 days before surgery to reach steady-state drug blood concentrations and
was continued for 6 days. In the control group, 1 mL/d of sterile saline solution was
orally administered 2 days before surgery and was continued for 6 days. To observe the
effects of nebivolol, cutaneous blood flow was examined using a laser Doppler flow-
meter before and after surgery on days 1, 3, 5, and 7, and flap tissue, malondialdehyde
(MDA) and glutathione (GSH) concentrations, and superoxide dismutase (SOD) ac-
tivity were measured 7 days postsurgery. Flap viability was evaluated 7 days after
surgery by measuring necrotic flap area and total flap area.
RESULTS: All 20 rats (nebivolol group, n = 10; control group, n = 10) survived
throughout the study period. Mean (SD) MDA concentration was significantly lower
in the nebivolol group than in the control group (69.25 [5.82} vs 77.67 [6.87} nmollg
tissue; P = 0.009). GSH concentration was significantly higher in the nebivolol group
than in the control group (2.14 [0.15} vs 1.88 [0.22} nmollmg tissue; P = 0.004).
SOD activity was significantly greater in the nebivolol group than in the control
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group (49.28 [5.49) vs 42.09 [4.95) U/g tissue; P = 0.007). The percentage of the
flap that was necrotic was significantly lower in the nebivolol group than in the con-
trol group (40.27 [4.08) vs 48.87 [6.35); P = 0.007).
CONCLUSIONS: This small, experimental, in vivo animal study found that
nebivolol was associated with reduced necrotic random pattern skin flap area. Further
srudies are needed to clarify these findings. (Curr Ther Res Clin Exp. 2008;69:449-
458) © 2008 Excerpta Medica Inc.
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INTRODUCTION
Skin flaps are commonly used to treat soft tissue defects in reconstructive surgery, bur
necrosis remains a serious complication.1.2While the pathophysiology of skin necrosis
is complex, 2 mechanisms have been implicated in promoting postsurgical flap
damage: (1) neutrophil infiltration caused by ischemia-reperfusion (I/R) injury; and
(2) vascular thrombosis caused by surgical trauma. 1- 5 Many factors may be involved
in I/R injury, including neutrophils and superoxide radicals. 1-8 An incomplete ische-
mic state accompanied by tissue damage is seen in the distal region of random pattern
skin flaps.9 Moreover, cutaneous blood flow initially decreases immediately after skin
flap surgery in the distal region of random pattern skin flaps but increases signifi-
cantly within 24 hours after flap elevation, as seen in I/R injury. 10,1 I Sufficient blood
flow is essential for survival of these flaps, and poor flap design, injury to the flap
vascular system, or I/R injury may cause partial or complete flap 10ss.1O
Reper/usion injury refers to the cellular damage that occurs when an insufficient
amount of blood is supplied to a region of the body, followed by the resumption of
sufficient blood flow.6 During this process, a large amount of molecular oxygen is
supplied to the tissues, and an abundant amount of reactive oxygen species (ROSs)
is produced.6,7 In biological systems, during multiple physiologic and pathophysio-
logic processes, ROS molecules that are generated are thought to be involved in
I/R injury.6,10,12 Reperfusion of ischemic flaps increases the effect of early ischemic
injury by releasing ROSs and accumulating activated neutrophils. 3,6,9,10 Proteins,
carbohydrates, lipids, and nucleic acids can be damaged by these species.6,13 Organ-
isms have enzymatic (superoxide dismutase [SOD), glutathione [GSH} peroxidase,
and catalase) and nonenzymatic (GSH, carotenes, ascorbic acid, and ubiquinol)
antioxidative defense mechanisms.6,7 When the equilibrium between the production
and the destruction of ROSs is upset, excess ROSs are produced and tissues are ex-
posed to oxidative injury.6,7 Numerous studies have investigated methods for improv-
ing survival, many of which have focused on improving viability through pharmaco-
logic manipulation.8- 2o
Nebivolol is a selective BI-adrenoreceptor blocking agent that possesses a pharma-
codynamic profile and a chemical structure that are different from traditional
B-blockers.2l ,22 Nebivolol has peripheral vasodilating properties that are mediated by
the modulation of the endogenous production of nitric oxide (NO), as well as other
antioxidative effects.2l- 25 The drug has also been reported to have antiaggregatory and
450
K. GIDEROGLU ET AL.
anti-inflammatory properties. 24,25 Although nebivolol has been reported to have anti-
oxidative, anti-inflammatory, antiaggregatory, and vasodilatory effects, its effect on
ischemic flap survival has not, to our knowledge, been investigated. A search of the
literature using the PubMed database did not find any articles on the effects of nebivo-
101 on ischemic flap survival.
This experimental study was designed to investigate the effects of nebivolol on
random pattern skin flap survival in rats.
MATERIAL AND METHODS
ANIMALS AND SURGICAL TECHNIQUE
Male Wistar rats weighing 290 to 310 g were supplied by Haydarpasa Numune
Education and Research Hospital's Animal Laboratory, Istanbul, Turkey. This study
was approved by The Animal Research Committee of the Haydarpasa Numune Edu-
cation and Research Hospital. The protocols and laboratory standards were in accor-
dance with the local Animal Care Committee.
The rats were randomly divided into 2 groups-the nebivolol group and the con-
trol group-using a computer-based number-generation technique. In the nebivolol
group, oral nebivolol 50 mg/kg/d (l mL of a racemic solution of nebivolol) was
started 2 days before surgery to reach steady-state drug blood concentrations and
was continued for 6 days. In the control group, oral saline 1 mL/d was started 2 days
before surgery and was continued for 6 days. The surgeon was blinded to the treat-
ment group. The rats were anesthetized with ketamine (50 mg/kg intraperitoneally
(IP)) and xylazine (5 mg/kg IP). The dorsal skin of each rat was prepared by clip-
ping the hair and applying hair remover. The caudally-based dorsal flap was located
in reference to anatomic landmarks and extended from the tip of the scapula to the
hip joints. The lateral margins were 1.5 em to either side of the midline, making
the flap -3 x 10 em. An additional triangular 3-cm segment of skin was removed
from the apex of the wound. This segment was positioned in the wound near the
base of the flap after removing the panniculus carnosus from its underside. The
wound was then closed, with this skin incorporated in the closure as a graft. In this
manner, complete isolation of the base of the flap was obtained without kinking the
flap pedicle, while allowing a contoured closure of the cephalic portion of the
wound. The flap, now completely isolated from the underlying bed, was positioned
on top of the closed wound. 26
LASER DOPPLER FLOWMETRY
Laser Doppler flowmeter (Laserflo BPM2, Vasamedics LLC, St. Paul, Minnesota)
measurements were obtained in all rats by a second investigator (ED.) who was
blinded to treatment group. The measurements were taken at a standardized flap loca-
tion (3 em distal from the base of the flap at the midline). After each animal was
anesthetized with pentobarbital, the output was recorded in milliliters per minute per
100 g of tissue and was a relative measurement of microvascular nurrient perfusion.
The laser Doppler flow was zeroed on the neurral-colored faceplate. All measurements
were done when the probe, which was heated to 40°C, had been placed flat on the skin
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for 60 seconds. Standard probe adhesive strips were used to keep the probe on skin.
The laser Doppler flow recordings were performed immediately before and after the
flap surgery and 1, 3, 5, and 7 days after surgery. The mean of these 6 measurements
was used for each rat.
BIOCHEMICAL ANALYSES
A full-thickness, 3-mm punch biopsy of the skin flap was taken from the center of
each flap 12 hours after the onset of reperfusion while the rats were lightly anesthe-
tized. 3,10 Tissue samples were stored at -80ae. A third investigator (G.B.) who was
blinded to the study groups performed the biochemical analyses. Fifty milligrams of
frozen flap tissue specimen cut into pieces using blades on dry ice were homogenized
in 1.15% potassium chloride buffer 0:9 w/v) using a manual glass homogenizer for
- 5 minutes and flushed by centrifugation for -10 seconds to remove large pieces of
debris. The supernatant was used for analysis. 1O
Malondialdehyde (MDA) concentration of the homogenates was determined spec-
trophotometrically by measuring the presence of thiobituric acid-reactive substances. 27
Results were expressed as nanomoles per gram of tissue.
GSH concentration was measured spectrophotometrically using Elman's reaction. 28
Results were expressed as nanomoles per milligram of tissue.
SOD enzyme activity was measured based on the production of hydrogen peroxide
from xanthine by xanthine oxidase and the reduction of nitroblue tetrazolium, as
previously described. 29 Results were expressed as units per gram of tissue.
SKIN FLAP SURVIVAL
Skin flap survival was the primary end point in this study. A fourth investigator
(R.E.) who was blinded to the study groups assessed skin flap survival on postopera-
tive day 7. Gross observation was used to identify the demarcation between viable
tissue (characterized by soft, rosy, warm skin with hair) and necrotic tissue (character-
ized by stiff, dark, cool skin without hair).3o The entire flap and the necrotic and vi-
able portions were traced onto a transparent cellophane sheet and transferred onto
graph paper with a 1-mm2 grid. 2 The area of necrosis was expressed as a percentage
of the entire flap area (necrotic flap percentage = necrotic flap area/total area x 100).
After skin flap survival was assessed, the rats were euthanized on postoperative day 7
using an overdose of sodium pentothal injected IP.
STATISTICAL ANALYSIS
Data were reported as mean (SD). SPSS for Windows, version 10.0 (SPSS, Inc.,
Chicago, Illinois) was used for statistical analysis. Because the results of laser Doppler
flow were distributed normally according to the Kolmogorov-Smirnov test, a t test
was used to compare the laser Doppler flows between the nebivolol and the control
groups. However, because the results of the survival proportions and biochemical
analyses were not distributed normally according to the Kolmogorov-Smirnov test,
they were compared using the nonparametric Mann-Whitney U test. P < 0.05 was
considered significant.
452
K. GIDEROGLU ET AL.
RESULTS
Twenty rats (mean [SD] weight, 200 [7.1] g) were randomly divided into 2 groups-
the nebivolol group (n = 10) and the control group (n = 10). All rats survived
throughout the study period.
LASER DOPPLER FLOWMETRY
The results of the laser Doppler flowmeter measurements are summarized in Table I.
Blood flow was significantly greater in the nebivolol group than in the control group
at all 6 measurements (all, P = 0.00l). Nebivolol was associated with increased skin
blood flow and improved blood circulation in the skin flaps.
BIOCHEMICAL ASSAYS
MDA concentration was significantly lower in the nebivolol group than in the
control group (69.25 [5.82] vs 77.67 [6.87] nmol/g tissue; P = 0.009). GSH concen-
tration (2.14 [0.15] vs 1.88 [0.22] nmol/mg tissue; P = 0.004) and SOD enzyme
activity (49.28 [5.49] vs 42.09 [4.95] Dig tissue; P = 0.007) were significantly higher
in the nebivolol group than in the control group (Table II).
Table I. Mean (SO) laser Doppler flowmeter findings in the nebivolol and the control
groups (N = 20). All measurements were mL/min per 100 g tissue.
Time Point
Immediately before surgery
Immediately after surgery
Day 1
Day 3
Day 5
Day 7
*p = 0.001 versus control group.
Nebivolol (n = 10)
97.13 (2.04)*
37.99 (2.23)*
45.67 (2.04)*
46.69 (1.94)*
54.70 (1.41)*
56.93 (1.56)*
Control (n = 10)
90.64 (2.83)
29.60 (1.45)
35.20 (2.39)
36.86 (2.50)
42.00 (1.62)
43.97 (1.44)
Table II. Mean (SO) tissue malondialdehyde (MDA) and glutathione (G5H) concentra-
tions and superoxide dismutase (SOD) activity in the nebivolol and the control
groups 12 hours after reperfusion (N = 20).
Concentration
MDA, nmoljg tissue
GSH, nmoljmg tissue
SOD, Ujg tissue
*p = 0.009 versus control group.
t p = 0.004 versus control group.
tp = 0.007 versus control group.
Nebivolol (n = 10)
69.25 (5.82)*
2.14 (0.15)t
49.28 (5.49)t
Control (n =10)
77.67 (6.87)
1.88 (0.22)
42.09 (4.95)
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FLAP SURVIVAL
A significantly smaller percentage of the skin flap was necrotic in the nebivolol group
than in the control group (40.27 [4.cl8} vs 48.87 [6.35}; P = 0.007) (Table III).
DISCUSSION
Cutaneous blood flow initially decreases immediately after skin flap surgery in the
distal region of random pattern skin flaps but increases significantly within 24 hours
after flap elevation.lO,ll An incomplete ischemic state with tissue damage occurs in
the distal region of a random pattern skin flap.9 An ischemic zone that may undergo
necrosis is also likely in the distal portion.2,lO Tissue ischemia induced by leukocyte
inflammation and inadequate blood flow was believed to be the principal factor pre-
disposing a patient to flap tissue necrosis.1-5Since an ischemic flap is a major surgical
problem that may cause prolonged hospitalization, pharmacologic agents that de-
crease the detrimental tissue and vascular changes may provide great benefits.
Several treatments may improve skin flap survival, including anti-inflammatory
drugs such as prednisolone3l ; vasodilatory agents such as prostacyclin, nifedipine, nitro-
glycerin, and N015,18,32; and the fibrinolysis of clotted blood in flap vessels with strep-
tokinase. 33 Other approaches include restoration of high levels of energy-rich phosphate
compounds such as fructose-l,6-diphosphate20; removal of damaging free radicals by
scavengers such as SOD, allopurinol, L-arginine, melatonin, and vitamins A and
Ell,13,34,35; immunosuppression with cyclosporin A and azathioprine3l ; inhibition of
coagulation with anticoagulants such as aspirin, clopidogrel, and heparin l,2; and modu-
lation of neutrophil activity with agents such as fucoidin. 3 In the present study, nebivo-
101 was associated with a significant increase in the survival of skin flaps. We think that
this improvement may be a result of its antioxidative, anti-inflammatory, anticoagulant,
and vasodilating properties and its protective effects against I/R injury. Improving flap
survival using anticoagulants and vasodilatory drugs has been widely studied. 15 ,18,32
Nebivolol has been reported to decrease platelet activation and increase cutaneous
blood flow. 23 ,24 However, the anticoagulant properties of nebivolol were not exam-
ined in this study; instead, its effects on cutaneous blood flow were assessed using
a laser Doppler flowmeter. Throughout the study, the nebivolol-treated group was
found to have significantly higher cutaneous blood flow in flaps than the control
group. In our opinion, higher blood flow with nebivolol treatment immediately
after surgery may reduce ischemic injury in the early period after flap placement and
may be one of the major mechanisms by which nebivolol improved skin flap survival
in this model.
Table III. Mean (SD) percentage of the necrotic flap tissue in the
nebivolol and the control groups (N = 20).
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Necrotic flap tissue, %
*p =0.007 versus control group.
Nebivolol (n = 10)
40.27 (4.08)*
Control (n = 10)
48.87 (6.35)
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It has been well established that ROSs and inflammatory cells are major mediators
of I/R injury in experimental random pattern flaps and free flaps.1,3,5-11,31-38 There-
fore, the current study focused on investigating the protective effects of nebivolol on
survival of random pattern skin flaps by measuring MDA and GSH concentrations
and SOD activity. Additionally, cutaneous blood flow was measured using a laser
Doppler flowmeter to explore the flap circulation.
The MDA concentration was significantly higher in the control group than in
the nebivolol-treated group. As an end product of lipid peroxidation, MDA is an
indicator of the damage caused by free radicals to components of the cell mem-
brane. 21 This may be due to 2 mechanisms: (1) blood flow increased by nebivolol,
probably resulting in a decrease in the size of the ischemic zone in the distal flap
region and decreased ischemic injury; and (2) nebivolol probably attenuated the
increase of MDA concentration in the flap tissue by directly eliminating ROSs
and increasing antioxidant enzyme activity. In our opinion, the combination of
these 2 mechanisms decreased the MDA concentration because nebivolol therapy
was previously found to suppress lipid peroxidation, activate antioxidant en-
zymes, and increase cutaneous blood flow. 21 ,23 As nebivolol increased blood flow
and reduced ischemic and oxidative injury to cellular structures, the concentra-
tion of the intracellular antioxidant GSH, which is otherwise oxidized when in-
activating free radicals, was significantly higher in the nebivolol group than the
control group. Therefore, it appears that the antioxidant effects of nebivolol on
lipid peroxidation do not involve the expenditure of tissue GSH stores, but that
the antioxidant pool is further sustained by the action of nebivolol. Moreover, the
reduction in antioxidant capacity caused by I1R injury may have been reversed by
nebivolol treatment.
SOD is one of the most important endogenous free radical scavengers, and exoge-
nous SOD is one of the treatments that has been found to improve skin flap survivaP4
In this study, SOD enzyme activity in the nebivolol group was found to be signifi-
cantly higher than in the control group, supporting the protective effect of nebivolol
on skin flap survival in tissue injury. We did not investigate the anti-inflammatory
effects of nebivolol in skin flap survival, but nebivolol was found to reduce the expres-
sion of proinflammatory genes in endothelial cells and vascular smooth muscle cells
in vitro, whereas metoprolol did not. 25 Nebivolol has also been found to inhibit
neointima formation by reducing smooth muscle cell proliferation and macrophage
accumulation.25
Considering the increased blood flow and reduced ischemic and oxidative damage
associated with nebivolol treatment, nebivolol's protective actions in the current study
are believed to be a result of its antioxidative and vasodilating activities. Our results
are consistent with studies that found that nebivolol administration reduced MDA
concentration and increased GSH concentration, SOD activity, and cutaneous blood
flow. 21- 25 In this study, nebivolol was associated with a significantly reduced propor-
tion of skin flap necrosis. The antiaggregatory and anti-inflammatory effects of nebivo-
101 may playa synergistic role with its antioxidant and vasodilating effects in improv-
ing random pattern skin flap survival.
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STUDY LIMITATIONS
Assessing the percentage of skin flap necrosis by tracing on a transparent sheet and
transferring onto graph paper was a limitation of this study because the method is less
precise than using a computer program to analyze a digital picture. However, the
method we used is among the methods commonly used in making this type of assess-
ment. 2 Another limitation of this study was that the antiaggregatory and anti-
inflammatory effects of nebivolol were not investigated. We found that the initial
blood flows were higher in the nebivolol-treated group immediately before the
surgery. It is well known that nebivolol is associated with cutaneous vasodilatation. 23
Accordingly, in our opinion, the higher blood flows were due to nebivolol being
administered 2 days prior to surgery.
CONCLUSIONS
The present study found that nebivolol, a new generation selective pt-adrenoreceptor
blocker, was associated with significantly reduced random pattern skin flap necrosis
in this animal model. Further investigations with larger animal models are needed,
especially studies of the mechanisms of the antiaggregatory and anti-inflammatory
effects of nebivolol in an I1R injury model.
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